Atopic Dermatitis — Probiotics and Breastmilk Decrease Risk of Atopic Dermatitis in Premature Infants
Citation(s)
Altobelli E, Angeletti PM, Verrotti A, Petrocelli R The Impact of Human Milk on Necrotizing Enterocolitis: A Systematic Review and Meta-Analysis. Nutrients. 2020 May 6;12(5):1322. doi: 10.3390/nu12051322.
Cuna A, Morowitz MJ, Ahmed I, Umar S, Sampath V Dynamics of the preterm gut microbiome in health and disease. Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1;320(4):G411-G419. doi: 10.1152/ajpgi.00399.2020. Epub 2021 Jan 13.
Damm JA, Smith B, Greisen G, Krogfelt KA, Clausen ML, Agner T The influence of probiotics for preterm neonates on the incidence of atopic dermatitis-results from a historically controlled cohort study. Arch Dermatol Res. 2017 May;309(4):259-264. doi: 10.1007/s00403-017-1725-4. Epub 2017 Mar 7.
David TJ, Ewing CI Atopic eczema and preterm birth. Arch Dis Child. 1988 Apr;63(4):435-6. doi: 10.1136/adc.63.4.435.
Fenton TR, Kim JH A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013 Apr 20;13:59. doi: 10.1186/1471-2431-13-59.
Fuleihan RL The hygiene hypothesis and atopic disease. Curr Opin Pediatr. 2002 Dec;14(6):676-7. doi: 10.1097/00008480-200212000-00004. No abstract available.
Gdalevich M, Mimouni D, David M, Mimouni M Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies. J Am Acad Dermatol. 2001 Oct;45(4):520-7. doi: 10.1067/mjd.2001.114741.
Hahn WH, Kim J, Song S, Park S, Kang NM The human milk oligosaccharides are not affected by pasteurization and freeze-drying. J Matern Fetal Neonatal Med. 2019 Mar;32(6):985-991. doi: 10.1080/14767058.2017.1397122. Epub 2017 Nov 6.
Lima PA, Carvalho Md, Costa AC, Moreira ME Variables associated with extra uterine growth restriction in very low birth weight infants. J Pediatr (Rio J). 2014 Jan-Feb;90(1):22-7. doi: 10.1016/j.jped.2013.05.007. Epub 2013 Oct 22.
Martinez FD, Guerra S Early Origins of Asthma. Role of Microbial Dysbiosis and Metabolic Dysfunction. Am J Respir Crit Care Med. 2018 Mar 1;197(5):573-579. doi: 10.1164/rccm.201706-1091PP. No abstract available.
Nagasaki T, Tabuchi T, Matsumoto H, Horimukai K Age-specific associations of early daycare, older siblings, severe airway infection, and preterm birth with subsequent atopic diseases. Pediatr Allergy Immunol. 2022 Apr;33(4):e13771. doi: 10.1111/pai.13771.
Niele N, van Zwol A, Westerbeek EA, Lafeber HN, van Elburg RM Effect of non-human neutral and acidic oligosaccharides on allergic and infectious diseases in preterm infants. Eur J Pediatr. 2013 Mar;172(3):317-23. doi: 10.1007/s00431-012-1886-2. Epub 2012 Nov 7.
Nolan LS, Rimer JM, Good M The Role of Human Milk Oligosaccharides and Probiotics on the Neonatal Microbiome and Risk of Necrotizing Enterocolitis: A Narrative Review. Nutrients. 2020 Oct 6;12(10):3052. doi: 10.3390/nu12103052.
Nutten S Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66 Suppl 1:8-16. doi: 10.1159/000370220. Epub 2015 Apr 24.
Olsen R, Greisen G, Schroder M, Brok J Prophylactic Probiotics for Preterm Infants: A Systematic Review and Meta-Analysis of Observational Studies. Neonatology. 2016;109(2):105-12. doi: 10.1159/000441274. Epub 2015 Dec 2.
Sherman PM, Cabana M, Gibson GR, Koletzko BV, Neu J, Veereman-Wauters G, Ziegler EE, Walker WA Potential roles and clinical utility of prebiotics in newborns, infants, and children: proceedings from a global prebiotic summit meeting, New York City, June 27-28, 2008. J Pediatr. 2009 Nov;155(5):S61-70. doi: 10.1016/j.jpeds.2009.08.022. Erratum In: J Pediatr. 2010 Feb;156(2):344.
Simpson A, Brough HA, Haider S, Belgrave D, Murray CS, Custovic A Early-life inhalant allergen exposure, filaggrin genotype, and the development of sensitization from infancy to adolescence. J Allergy Clin Immunol. 2020 Mar;145(3):993-1001. doi: 10.1016/j.jaci.2019.08.041. Epub 2019 Oct 17.
Thureen PJ Early aggressive nutrition in very preterm infants. Nestle Nutr Workshop Ser Pediatr Program. 2007;59:193-204; discussion 204-8. doi: 10.1159/000098536.
Uberos J Perinatal microbiota: review of its importance in newborn health. Arch Argent Pediatr. 2020 Jun;118(3):e265-e270. doi: 10.5546/aap.2020.eng.e265. English, Spanish.
Voigt J, Lele M Lactobacillus rhamnosus Used in the Perinatal Period for the Prevention of Atopic Dermatitis in Infants: A Systematic Review and Meta-Analysis of Randomized Trials. Am J Clin Dermatol. 2022 Nov;23(6):801-811. doi: 10.1007/s40257-022-00723-x. Epub 2022 Sep 26.
Yang YW, Tsai CL, Lu CY Exclusive breastfeeding and incident atopic dermatitis in childhood: a systematic review and meta-analysis of prospective cohort studies. Br J Dermatol. 2009 Aug;161(2):373-83. doi: 10.1111/j.1365-2133.2009.09049.x. Epub 2009 Feb 23.
Zachariassen G Nutrition, growth, and allergic diseases among very preterm infants after hospital discharge. Dan Med J. 2013 Feb;60(2):B4588.
Probiotics and Breastmilk Are Associated With a Decreased Risk of Atopic Dermatitis in Very Low Birth Weight Premature Infants
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.